Aclarion, Inc. (ACON): Total Liabilities
$837.3K
As of 2025-12-31
$1.04M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $837.3K | -27.4% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $1.15M | n/a | 2026-03-18, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Aclarion, Inc. (ACON) | 2025-12-31 | $837.3K | -27.4% |
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $26.52M | +7.1% |
| YD Bio Ltd (YDES) | 2025-12-31 | $16.64M | n/m |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $637.9K | -69.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| CapForce Inc. (CFOR) | 2025-12-31 | $6.20M | +149.7% |
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
Compare ACON, SERA, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗